{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:41:49Z","timestamp":1777470109444,"version":"3.51.4"},"reference-count":27,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2017,12,12]]},"DOI":"10.3233\/bd-160256","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T11:44:50Z","timestamp":1496749490000},"page":"49-53","source":"Crossref","is-referenced-by-count":7,"title":["The evaluation of the effect of metformin on breast fibrocystic disease"],"prefix":"10.1177","volume":"37","author":[{"given":"A.","family":"Talaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"10","key":"10.3233\/BD-160256_ref1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/aje\/kwh318","article-title":"A case-control study of risk factors for fibrocystic breast conditions","volume":"160","author":"Wu","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"16","key":"10.3233\/BD-160256_ref2","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM198210143071611","article-title":"Sounding board. Fibrocystic \u201cdisease\u201d of the breast\u2013a nondisease?","volume":"307","author":"Love","year":"1982","journal-title":"The New England J Medicine"},{"issue":"9","key":"10.3233\/BD-160256_ref3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.mri.2008.02.004","article-title":"Magnetic resonance imaging features of fibrocystic change of the breast","volume":"26","author":"Chen","year":"2008","journal-title":"Magn Reson Imaging"},{"issue":"8","key":"10.3233\/BD-160256_ref4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI14178","article-title":"The blooming of the French lilac","volume":"108","author":"Witters","year":"2001","journal-title":"J Clin Invest"},{"key":"10.3233\/BD-160256_ref5","first-page":"490","article-title":"Vitamin E and benign breast \u201cdisease\u201d: a double-blind, randomized clinical trial","volume":"97","author":"Ernster","year":"1985","journal-title":"Surgery"},{"key":"10.3233\/BD-160256_ref6","first-page":"5","article-title":"Spectrum of benign breast disorders in a university hospital","volume":"95","author":"Khanna","year":"1997","journal-title":"J Ind Med Assoc"},{"key":"10.3233\/BD-160256_ref7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1524-4741.2009.00768.x","article-title":"Therapeutic effects of vitamin E on cyclic mastalgia","author":"Parsay","year":"2009","journal-title":"Breast J"},{"issue":"1","key":"10.3233\/BD-160256_ref8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1701-2163(16)32027-8","article-title":"Mastalgia","volume":"28","author":"Rosolowich","year":"2006","journal-title":"J Obstet Gynaecol Can."},{"issue":"5","key":"10.3233\/BD-160256_ref9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1185\/030079904125003377","article-title":"Evidence for the management of mastalgia","volume":"20","author":"Gumm","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.3233\/BD-160256_ref10","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.4161\/cc.10.17.16359","article-title":"Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2\/IGF-1 receptor interactions","volume":"10","author":"Liu","year":"2011","journal-title":"Cell Cycle"},{"key":"10.3233\/BD-160256_ref11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s11912-010-0139-7","article-title":"Obesity and cancer risk: recent review and evidence","volume":"13","author":"Basen-Engquist","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"10.3233\/BD-160256_ref12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: anutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nature Rev Mol Cell Biol"},{"issue":"4","key":"10.3233\/BD-160256_ref13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/pcan.2012.16","article-title":"Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer","volume":"15","author":"Colquhoun","year":"2012","journal-title":"Prostate Cancer Prostatic Diseases"},{"issue":"10","key":"10.3233\/BD-160256_ref14","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.2337\/dc11-1447","article-title":"Metformin and Colorectal Cancer Risk in Diabetic Patients","volume":"34","author":"Ioannou","year":"2011","journal-title":"Diabetes Care"},{"key":"10.3233\/BD-160256_ref15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-008-9916-5","article-title":"Therapeutic metformin\/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model","volume":"113","author":"Phoenix","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-160256_ref16","doi-asserted-by":"crossref","first-page":":3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"Jiralerspong","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.3233\/BD-160256_ref17","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation inbreast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res"},{"key":"10.3233\/BD-160256_ref18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-006-9471-x","article-title":"Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer","volume":"106","author":"Mulligan","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-160256_ref19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethyl biguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J Biol Chem"},{"key":"10.3233\/BD-160256_ref20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","article-title":"Metformin, independent of AMPK, inhibits mTORC1 in a Rag GTPase-dependent manner","volume":"11","author":"Kalender","year":"2010","journal-title":"Cell Metab"},{"key":"10.3233\/BD-160256_ref21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-010-1224-1","article-title":"Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents","volume":"126","author":"Goodwin","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-160256_ref22","doi-asserted-by":"crossref","unstructured":"GandiniSara, Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders, Cancer Prev Res, 2014.","DOI":"10.1158\/1940-6207.CAPR-13-0424"},{"key":"10.3233\/BD-160256_ref23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4048\/jbc.2015.18.3.264","article-title":"Association between metformin therapy and breast cancer incidence and mortality: evidence from a meta-analysis","author":"Yang","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.3233\/BD-160256_ref24","doi-asserted-by":"crossref","unstructured":"Dowling, Ryan JO , Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study, Breast Cancer Res, 32: 2015.","DOI":"10.1186\/s13058-015-0540-0"},{"issue":"4","key":"10.3233\/BD-160256_ref25","first-page":"EC06","article-title":"The Er\/Ki-67 proportion in breast tumours \u2013 an immunohistochemical study","volume":"10","author":"Rachna","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.3233\/BD-160256_ref26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-015-3307-5","article-title":"Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial","author":"Hadad","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-160256_ref27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/07357907.2014.889706","article-title":"Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer","author":"Kalinsky","year":"2014","journal-title":"Cancer Invest"}],"container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-160256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:38:18Z","timestamp":1777383498000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-160256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,12]]},"references-count":27,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/bd-160256","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,12]]}}}